![Esther Lukasiewicz-Hagai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Esther Lukasiewicz-Hagai
Corporate Officer/Principal chez
Clexio Biosciences Ltd.
Profil
Esther Lukasiewicz-Hagai is currently the Chief Medical Officer at Clexio Biosciences Ltd. She previously served as the Chief Executive Officer at FutuRx Ltd. for a brief period in 2018 and as a Director at Teva Pharmaceutical Industries Ltd. from 2012 to 2013.
She also held the position of Vice President-Clinical & Medical Affairs at Pluri, Inc. Dr. Lukasiewicz-Hagai holds a doctorate degree from Bar-Ilan University and a graduate degree and another doctorate degree from Université de Paris XI Paris Sud and Université de Paris 5 René Descartes, respectively.
Postes actifs de Esther Lukasiewicz-Hagai
| Sociétés | Poste | Début |
|---|---|---|
Clexio Biosciences Ltd.
 Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Develops novel therapies for patients suffering from neurological and psychiatric conditions | Corporate Officer/Principal | 01/09/2018 |
Anciens postes connus de Esther Lukasiewicz-Hagai
| Sociétés | Poste | Fin |
|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Directeur Général | 02/09/2018 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Private Equity Investor | 02/12/2013 |
| PLURI INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Esther Lukasiewicz-Hagai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Pluri, Inc.
 Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Bar-Ilan University
 Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris XI Paris Sud
 Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Clexio Biosciences Ltd.
Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Develops novel therapies for patients suffering from neurological and psychiatric conditions | Health Technology |
